Company: LIMN
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001410578-25-001746
Chunk: 243

Company: Liminatus Pharma, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 243
---
 2024 Loans           |   | Short-term debt, net, related parties |   | ​ |            850 | ​ |   |               850 |
| Amantes November 2024 Loans      |   | Short-term debt, net, related parties |   | ​ |            700 | ​ |   |               700 |
| Amantes January 2025 Loans       |   | Short-term debt, net, related parties |   | ​ |            300 | ​ |   |                 — |
| Prophase February 2025 Loan      |   | Short-term debt, net, related parties |   | ​ |            206 | ​ |   |                 — |
| Prophase March 2025 Loan         |   | Short-term debt, net, related parties |   | ​ |            207 | ​ |   |                 — |
| ​                                | ​ | ​                                     | ​ | ​ |              ​ | ​ | ​ |                 ​ |
| Short-term debt, related parties | ​ | ​                                     | ​ | $ |         20,686 | ​ | $ |            19,973 |

As of March 31, 2025 and December 31, 2024, the Company’s outstanding debt agreements are all classified as current as all are past due with the exception of the Prophase February 2025 Loan and the Prophase March 2025 Loan, which are due within one year and are classified as current in the accompanying unaudited condensed balance sheets. All of the loans are with related parties (see Note 4). As the Company’s loans are with related parties, the Company and its related parties have mutually agreed to defer repayment until a time that is mutually agreed upon between the Company and its related parties. Note 6. Members’ Deficit On May 20, 2018, the Company issued 10,000,000 Class A member units for $0.1 million to its Initial Member. On June 11, 2018, in connection with the Initial Member unit issuance, the Company granted equity-classified options to purchase 16,666,666 member units for $0.01 per unit to the Initial Member, which were exercised in April 2021 for $0.2 million in a non-cash transaction using the amounts in due to related parties. In May 2022, the Company issued 8,400,000 new Class A member units for $4.2 million, or $0.50